Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Miriam Calles Bastande

Miriam Calles Bastande

Institutions of which they are part

Research technician
Gene Therapy at Nervous System
Vall Hebron Institut de Recerca
Miriam Calles Bastande

Miriam Calles Bastande

Miriam Calles Bastande

Institutions of which they are part

Research technician
Gene Therapy at Nervous System
Vall Hebron Institut de Recerca

Related news

Motoneurones de la medul·la espinal

FDA grants orphan drug designation to a gene therapy for ALS

The treatment, licensed to Klotho Neurosciences, is based on a technology developed at the Universitat Autònoma de Barcelona (UAB) with the participation of VHIR.

Investigadora VHIR pipeta

European Partnership Opens a New Era in Rare Disease Research

The European Rare Diseases Research Alliance (ERDERA) kicked off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond.

tecniques-micro

VHIR leads a gene therapy study to stop the progression of neurodegenerative diseases

This gene therapy protects mice against cognitive deficits associated with aging, improves motor function, and delays the onset of diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease.

See more

Related professionals

Cristina Hernández Pascual

Cristina Hernández Pascual

Main researcher
Diabetes and Metabolism
Read more
Maria Gallego Rodriguez

Maria Gallego Rodriguez

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Jose J Barroso García

Jose J Barroso García

Research technician
Clinical Pharmacology
Read more
Marta Riba Barroso

Marta Riba Barroso

Research technician
Pediatric Neurology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.